Alan Menius is the newly appointed Chief Data Scientist at HAP Innovations, a consumer health technology company with a mission of helping people live healthy and independent lives. Prior to this role Alan spent 25 years at GlaxoSmithKline where he led advanced analytics teams responsible for leveraging disparate data sources and advanced analytics to inform the safety and effectiveness of medicines. Most recently Alan led the analytics efforts of the GSK/ Community Care North Carolina Medication Management Collaboration.
Alan helped initiate and lead the GSK SafetyWorks project where advanced semantic technologies and analytics were merged to develop pharmacovigilance analytics methods using observational data. These methods were further developed via the Observational Medical Outcomes Partnership (OMOP). Alan established and led the GSK Data Exploration and Data Mining laboratory at North Carolina State University. The analytics research performed at this center over the years resulted in GSK and N.C. State being awarded the ASA SPAIG award for outstanding partnership between industry and academia.
Alan is a member of the American Statistical Association and has participated in the Institute of Medicine’s Clinical Effectiveness Research Innovation Collaborative. He has also served as an elected member of the Quantitative Sciences in the Pharmaceutical Industry (QSPI) core team and as a member of SAS’s Analytics Customer Advisory Board.
Alan has over 20 publications in peer-reviewed journals and has given numerous invited presentations on advanced analytics at national and international meetings. Alan holds a B.S. in Biochemistry from North Carolina State University and a M.H.S. in Biometry from Duke University.